BioTech How to keep the BIOSECURE Act from hobbling U.S. biotech and pharma In a rare display of bipartisan agreement, Congress is getting serious about addressing China’s influence in key industries. This spring’s “TikTok ban” is the most Read More » Kendalle Burlin O’Connell September 12, 2024